Activity of a Novel Combined Antiretroviral Therapy of Gemcitabine and Decitabine in a Mouse Model for HIV-1

The emergence of drug resistance threatens to limit the use of current anti-HIV-1 drugs and highlights the need to expand the number of treatment options available for HIV-1-infected individuals. Our previous studies demonstrated that two clinically approved drugs, decitabine and gemcitabine, potent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Clouser, Christine L., Holtz, Colleen M., Mullett, Mary, Crankshaw, Daune L., Briggs, Jacquie E., O'Sullivan, M. Gerard, Patterson, Steven E., Mansky, Louis M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2012
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318345/
https://ncbi.nlm.nih.gov/pubmed/22271861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06161-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares